Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Renalytix Reports Full Year Fiscal 2021 Results

October 21, 2021
RNS Number : 7882P Renalytix PLC 21 October 2021   Renalytix plc (" Renalytix " or the " Company ")   Renalytix Reports Full Year Fiscal 2021 Results   LONDON and SALT LAKE CITY , October 21, 2021   - Renalytix plc   (NASDAQ: RNLX),  (LSE : RENX) an artificial intelligence-enabled in vitro

Renalytix to Report Q4 and Full Year Results

October 8, 2021
RNS Number : 4032O Renalytix PLC 08 October 2021     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results on October 21   LONDON and SALT LAKE CITY , October 8, 2021 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced

VA Health System roll-out & VP sales appointment

October 7, 2021
RNS Number : 2788O Renalytix PLC 07 October 2021     Renalytix plc (" Renalytix " or the " Company ")   Renalytix Launching KidneyIntelX in Veterans Health Administration Hospitals   Jed Fulk Appointed Vice President Sales, Government Accounts   NEW YORK and SALT LAKE CITY , October 7, 2021   -

Second Price Monitoring Extn

September 16, 2021
RNS Number : 0377M Renalytix PLC 16 September 2021   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

Second Price Monitoring Extn

September 15, 2021
RNS Number : 8680L Renalytix PLC 15 September 2021   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

Price Monitoring Extension

September 15, 2021
RNS Number : 8670L Renalytix PLC 15 September 2021   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

Update on MCIT Rule

September 14, 2021
RNS Number : 7773L Renalytix PLC 14 September 2021   This announcement contains inside information   Renalytix plc (" Renalytix " or the " Company ")   Update on MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics   NEW YORK , September 14, 2021 - Renalytix

Mount Sinai Initiates Scale-Up of KidneyIntelX

September 14, 2021
RNS Number : 6348L Renalytix PLC 14 September 2021   This announcement contains inside information   Renalytix plc (" Renalytix " or the " Company ")     Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX TM Enabled Health Care Model   Targeted testing run rate of 300 diabetic

Issue of shares and TVR

September 13, 2021
RNS Number : 6078L Renalytix PLC 13 September 2021       Renalytix plc (" Renalytix " or the " Company ")     Issue of shares under the 2020 employee share purchase plan and Total Voting Rights   NEW YORK and SALT LAKE CITY , September 13 2021 - Renalytix Plc   (NASDAQ: RNLX) (LSE: RENX)  

Director/PDMR Shareholding

September 6, 2021
RNS Number : 8886K Renalytix PLC 06 September 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 6 September 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 3,000
Displaying 1 - 10 of 167